Dowling-Meara Epidermolysis Bullosa SimplexSymptoms, Doctors, Treatments, Advances & More
Dowling-Meara Epidermolysis Bullosa Simplex Overview
Learn About Dowling-Meara Epidermolysis Bullosa Simplex
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Catherine Laprise practices practicing medicine in Saguenay, Canada. Ms. Laprise is rated as an Elite expert by MediFind in the treatment of Dowling-Meara Epidermolysis Bullosa Simplex. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Dowling-Meara Epidermolysis Bullosa Simplex, Dominant Dystrophic Epidermolysis Bullosa, Asthma, and Epidermolysis Bullosa.
Cristina Has practices practicing medicine in Freiburg, Germany. Ms. Has is rated as an Elite expert by MediFind in the treatment of Dowling-Meara Epidermolysis Bullosa Simplex. She is also highly rated in 33 other conditions, according to our data. Her clinical expertise encompasses Dominant Dystrophic Epidermolysis Bullosa, Dowling-Meara Epidermolysis Bullosa Simplex, Epidermolysis Bullosa, and Junctional Epidermolysis Bullosa.
St Vincent's Hospital Melbourne
Dedee Murrell practices practicing medicine in Fitzroy, Australia. Murrell is rated as an Elite expert by MediFind in the treatment of Dowling-Meara Epidermolysis Bullosa Simplex. They are also highly rated in 44 other conditions, according to our data. Their clinical expertise encompasses Epidermolysis Bullosa, Pemphigus, Pemphigus Vulgaris, and Pemphigus Foliaceus.
Summary: This is a phase II, intra-subject randomized, double-blind, vehicle-controlled, parallel, multicenter study to evaluate the safety and preliminary efficacy of ENERGI-F703EB Cream in subjects who are ≥ 18 years old with epidermolysis bullosa simplex (EBS), junctional epidermolysis bullosa (JEB), or dystrophic epidermolysis bullosa (DEB). In total, approximately 24 subjects will be enrolled from mul...
Summary: This Phase II clinical study will assess the efficacy, safety and tolerability of topical TolaSure Gel in adults and pediatric patients (2 years of age and older) diagnosed with localized, intermediate, or severe epidermolysis bullosa simplex (EBS). Each patient (40 to complete) will be enrolled in the study and will be randomized to receive either TolaSure Gel or a topical Placebo for daily appli...